Company intelligence
DCAT (Drug, Chemical & Associated Technologies Association)
The Premier Association for the Global Bio/Pharmaceutical Business Ecosystem
About DCAT (Drug, Chemical & Associated Technologies Association)
Founded in 1890, the Drug, Chemical & Associated Technologies Association, Inc. (DCAT) is a not-for-profit, corporate member-supported, and volunteer-led global business development association for companies engaged in the Bio/Pharmaceutical manufacturing value chain. DCAT has been providing a life-long collegial community for its Member Companies, and their representatives, for over 130 years. DCAT helps build relationships within its unique member company profile that includes the Bio/Pharmaceutical industry’s entire manufacturing value chain. DCAT creates objective, expert-driven education programs and informational services so its Member Companies can easily gain insight into industry market trends, best practices, and the issues impacting the industry. Membership in the DCAT organization provides real value by offering events, programs, services, branding opportunities, and more at affordable corporate membership rates. The DCAT organization ensures that Member Companies have an appropriate forum for high-level, strategic business meetings, timely educational sessions, and essential networking opportunities by hosting DCAT Week and the DCAT Annual Dinner each year in New York City.
Verified activity
Signals from DCAT (Drug, Chemical & Associated Technologies Association)
2 published signals
Products & Services
DCAT (Drug, Chemical & Associated Technologies Association) released a new Road to DCAT Week guide that serves as a month-by-month resource for planning DCAT Week activities.
Reported by DCAT (Drug, Chemical & Associated Technologies Association)
Presence & Recognition
DCAT (Drug, Chemical & Associated Technologies Association) featured Dave Schoneker of Black Diamond Regulatory Consulting and Chair of the IPEC-Americas Quality by Design/Composition Committee on the Production to Prescription podcast episode discussing excipient innovation.
Reported by DCAT (Drug, Chemical & Associated Technologies Association)